←Back to Expert Scholars
Translational Medicine / 转化医学POLE Hypermutated and Molecular, Endometrial
Ramez Eskander
MD
🏢UC San Diego Moores Cancer Center🌐USA
Associate Professor, Gynecologic Oncology
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ramez Eskander led NRG-GY018 establishing pembrolizumab plus chemotherapy in advanced endometrial cancer, with striking benefit in MMR-deficient disease. He is a gynecologic oncologist at UC San Diego Moores Cancer Center. His work anchors immunotherapy integration into endometrial cancer care.
Share:
🧪Research Fields 研究领域
NRG-GY018
pembrolizumab endometrial
gynecologic IO
clinical trials
molecular tailoring
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ramez Eskander 的研究动态
Follow Ramez Eskander's research updates
留下邮箱，当我们发布与 Ramez Eskander（UC San Diego Moores Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment